Loading viewer...
earnings
Format: PDF earnings
Telix Pharmaceuticals' H1 2023 results presentation covering the company's investigational radiopharmaceutical products and pipeline, including Illuccix® (Ga-68 gozetotide injection). The presentation outlines Telix's activities, financial results, and development progress as of August 2023.
annual_report
14 Pages
earnings
2 Pages
Martin Midstream Partners
Adani Transmission Q4 FY22 Results Presentation May 2022
earningsearnings
48 Pages
Adani Transmission Limited
Algoma Central 2025 Interim Report Q3 Earnings
earningsearnings
36 Pages
Algoma Central Corporation